DA CONSEGNARE A MANO A MONNEZZARELLA DRAGHI CONTE DI MAIO SPERANZA ARCURI FIGLIUOLO ET AL.

  Skip to main page content

Case Reports
. 2021 Jun;107:172-175.
doi: 10.1016/j.ijid.2021.04.053. Epub 2021 Apr 16.

First case of postmortem study in a patient vaccinated against SARS-CoV-2

Torsten Hansen  1 , Ulf Titze  2 , Nidhi Su Ann Kulamadayil-Heidenreich  3 , Sabine Glombitza  4 , Johannes Josef Tebbe  3 , Christoph Röcken  5 , Birte Schulz  2 , Michael Weise  3 , Ludwig Wilkens  4
Affiliations
Free PMC article

Abstract

A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity.

Keywords: Autopsy; Histology; RT-PCR; SARS-CoV-2; Vaccine.

Figures

Figure 1

Similar articles

See all similar articles

References

    1. Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120–128. doi: 10.1056/NEJMoa2015432. - DOI - PMC - PubMed
    1. Amit S., Regev-Yochay G., Afek A., Kreiss Y., Leshem E. Early rate reductions of SARS-CoV2-infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021;397(10277):875–877. doi: 10.1016/S0140-6736(21)00448-7. - DOI - PMC - PubMed
    1. Edler C., Schröder A.S., Aepfelbacher M., Fitzek A., Heinemann A., Heinrich F. Dying with SARS-CoV2 infection – an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020;134:1275–1284. doi: 10.1007/s00414-020-02336-7. - DOI - PMC - PubMed
    1. Kaltschmidt B., Fitzek A.D.E., Schaedler J., Förster C., Kaltschmidt C., Hansen T. Hepatic vasculopathy and regernative responses of the liver in fatal cases of COVID-19. Clin Gastroenterol Hepatol. 2021 doi: 10.1016/j.cgh.2021.01.044. In press. - DOI - PMC - PubMed
    1. Kim D.S., Rowland-Jones S., Gea-Mallorqui E. Will SARS-CoV-2 infecion elicit long-lasting protective or sterilizing immunity? Implications for vaccine strategies. Front Immunol. 2020;11:571481. doi: 10.3389/fimmu.2020.571481.eCollection2020. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Follow NLM

    • at
    Labels: , , , , , , , , , , , ,

    Nessun commento:

    Posta un commento

    Iscriviti a: Commenti sul post (Atom)

    Lettera aperta al signor Luigi di Maio, deputato del Popolo Italiano

    ZZZ, 04.07.2020 C.A. deputato Luigi di Maio sia nella sua funzione di deputato sia nella sua funzione di ministro degli esteri ...